Putikaranja: Benefits, Evidence & Safety

TL;DR

Putikaranja is the Ayurvedic name for the Indian elm tree, Holoptelea integrifolia: though scholars note the classical "karanja" identity is genuinely contested. Traditionally its bark and leaves are used for rheumatism, skin disorders and wounds. All modern evidence is preclinical (animal and lab studies); no human trial exists. (49 words. Sources: IAMJ 2013 identity review; BioMed Res Int 2014 review, PMID 24949441.)

What it is

Putikaranja (synonyms: chirbilva/chirabilva, putika) is an Ayurvedic tree drug whose botanical source is identified as Holoptelea integrifolia (Roxb.) Planch, of the elm family (Ulmaceae): the Indian elm, also called chilbil or papri. The parts used in tradition are the stem bark and leaves, described as bitter (tikta), astringent (kashaya), and thermogenic (ushna virya) (Bhuvad & Nishteswar, IAMJ 2013).

The identity is contested. A peer-reviewed Ayurvedic review notes "some controversy in establishing [the] true source of classical Karanja varieties": the Ayurvedic Pharmacopoeia of India describes Chirabilva (fruit) and Putikaranja (stem bark) with different botanical sources, while other authorities treat Chirabilva and Putikaranja as synonyms (IAMJ 2013). Charaka mentioned chirabilva among the bhedaniya and lekhaniya groups of herbs. Readers should treat "putikaranja" on a product label as a name with a disputed classical backstory, not a settled botanical fact.

Traditional use

In Ayurvedic literature the bark and leaves of putikaranja are credited with anti-inflammatory, digestive, carminative, laxative, anthelmintic, depurative, and urinary-astringent properties, and are traditionally used for rheumatism and rheumatic swellings, skin diseases (including scabies, ringworm, eczema, leucoderma, and leprosy in classical descriptions), wounds, intestinal worms, dyspepsia, flatulence, colic, hemorrhoids, edema, and diabetes (IAMJ 2013; IJCRT 2024 ethnobotanical review). Typical traditional applications include bark paste applied externally to swollen joints or skin lesions, and leaf decoctions. These are records of traditional and folk practice: not clinical proof of efficacy for any disease.

What modern research says

No human trial of putikaranja exists. The entire modern literature is preclinical. The most comprehensive summary is a 2014 peer-reviewed review (BioMed Research International, PMID 24949441), which found that in-vitro and animal (in-vivo) investigations of crude extracts and isolated compounds reported antibacterial, antifungal, analgesic, antioxidant, anti-inflammatory, anthelmintic, antidiabetic, antidiarrhoeal, adaptogenic, anticancer, wound-healing, hepatoprotective, larvicidal, antiemetic, CNS-depressant, and hypolipidemic activities (Ganie & Yadav 2014; PMCID PMC4052053).

Phytochemically, the review lists terpenoids, sterols, saponins, tannins, alkaloids, phenols, flavonoids, and glycosides, with isolated compounds including Holoptelin-A, Holoptelin-B, friedelin, epifriedelin, β-amyrin, stigmasterol, β-sitosterol, 1,4-naphthalenedione, betulin, and betulinic acid (PMC4052053). The review's own conclusion is cautious: further studies on the chemical constituents, their mechanisms, and, explicitly, the toxicity of crude extracts are still needed.

Honest summary. Putikaranja has a long traditional record and an active preclinical literature, but animal and cell studies cannot establish that it treats rheumatism, skin disease, diabetes, or wounds in people. There is no human evidence either way.

Safety & contraindications

No human safety data for putikaranja exist, and the 2014 review explicitly states that toxicity of the crude extracts and isolated compounds still needs assessment (PMC4052053). One concrete caution: Holoptelea integrifolia pollen is a documented airborne allergen in India, so people with pollen or plant allergies should be cautious with any preparation of this tree (cited in IJCRT 2024). There are no published data on use in pregnancy, breastfeeding, or children. Safety data are limited: talk to a clinician before use, and do not use traditional bark or leaf preparations as a substitute for medical care of skin infections, wounds, or diabetes.

FAQs

What is putikaranja?

Putikaranja (also called chirbilva or putika) is an Ayurvedic tree drug traditionally identified with the Indian elm, Holoptelea integrifolia. Its bark and leaves are used in classical practice for rheumatism, skin disorders, and wounds: though scholars note the classical "karanja" botanical identity is genuinely disputed.

Is its botanical identity certain?

No. A peer-reviewed Ayurvedic review documents real controversy: the Ayurvedic Pharmacopoeia of India assigns different botanical sources to Chirabilva (fruit) and Putikaranja (stem bark), while other authorities treat the two names as synonyms for Holoptelea integrifolia. Any label claim about "authentic" putikaranja should be read with that dispute in mind.

What is putikaranja traditionally used for?

Traditionally its bark and leaves are used for rheumatic swellings, skin conditions (scabies, ringworm, eczema, leucoderma in classical descriptions), wounds, intestinal worms, digestive complaints, hemorrhoids, and edema. These are traditional and folk uses, not clinically proven effects.

Is there scientific proof it works?

No human trials exist. Modern research is entirely preclinical: lab and animal studies of extracts and isolated compounds have reported anti-inflammatory, antimicrobial, antidiabetic, and wound-healing activities (reviewed in BioMed Res Int 2014, PMID 24949441). Animal and cell findings cannot prove the tree treats disease in people.

Can putikaranja treat diabetes?

There is no human evidence that it can. Antidiabetic effects have been reported only in animal studies of leaf extracts. Diabetes requires proper medical diagnosis and management; a traditional tree preparation is not an established treatment, and delaying real care can be dangerous.

Is it safe?

No human safety data exist, and a 2014 review explicitly calls for toxicity studies of its extracts. One specific caution: its pollen is a known airborne allergen in India, so allergy-prone people should be careful. There are no data for pregnancy, breastfeeding, or children.

Which part of the tree is used?

Classical and folk practice uses mainly the stem bark and the leaves: bark paste applied externally for swellings and skin problems, and leaf preparations taken or applied for various complaints. The Ayurvedic Pharmacopoeia of India describes Putikaranja as the stem bark specifically.

Sources

This article is for educational purposes only and is not medical advice. Consult a qualified practitioner before using any Ayurvedic formulation.